Form 4: Vicor Director Exercises, Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Vicor Corp. Director Andrew D'Amico exercised stock options and sold 2,071 common shares for approximately $196,000, as part of a pre-arranged 10b5-1 trading plan.
Summary
- Andrew D'Amico, a Director of Vicor Corp., executed multiple transactions on October 24, 2025, involving the exercise of Non-Qualified Stock Options and the subsequent sale of common stock.
- He exercised 1,154 options with an exercise price of $69.04 and 917 options with an exercise price of $41.61, acquiring a total of 2,071 shares of common stock.
- Concurrently, he sold all 2,071 acquired shares of common stock in the open market at prices ranging from $94.07 to $96.00 per share.
- These sales were conducted pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on September 12, 2024.
- Following these transactions, D'Amico beneficially owns 1,154 Non-Qualified Stock Options with an exercise price of $69.04 and 8,748 Non-Qualified Stock Options with an exercise price of $41.61.
Sentiment
Score: 5
Explanation: The transactions represent a pre-planned liquidity event by a director, involving both option exercise and subsequent sale of shares under a Rule 10b5-1 plan. This is a routine insider transaction and does not inherently signal strong positive or negative sentiment regarding the company's immediate prospects.
Positives
- The director exercised stock options, indicating perceived value in the company's stock at the time of option grant.
- Sales were conducted under a Rule 10b5-1 trading plan, suggesting a pre-planned liquidity event rather than a reaction to recent company performance or undisclosed information.
Negatives
- A director sold a significant number of shares (2,071 shares) in the open market, which can sometimes be viewed with caution by investors.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The sale of shares by a director, even if pre-planned, could be viewed with mixed sentiment, though the 10b5-1 plan mitigates concerns of opportunistic selling.
Key Dates
| Date | Description |
|---|---|
| 09/12/2024 | Rule 10b5-1 trading plan adopted by the reporting person. |
| 05/02/2025 | Expiration date for some options (2 years from vesting date). |
| 06/24/2025 | Date exercisable for Non-Qualified Stock Options with $69.04 exercise price. |
| 10/24/2025 | Date of all reported common stock acquisitions, dispositions, and derivative security transactions. |
| 10/28/2025 | Signature date of the reporting person's attorney-in-fact for the filing. |
| 06/24/2030 | Expiration date for Non-Qualified Stock Options with $69.04 exercise price. |
Recommendation
holdThe filing details a pre-planned insider sale by a director under a Rule 10b5-1 plan. While insider selling can sometimes be a negative signal, the pre-arranged nature of these transactions suggests a liquidity event rather than a reaction to new, adverse information. Therefore, this specific filing alone does not provide a strong basis for a 'buy' or 'sell' recommendation, leading to a 'hold' stance as it's a routine, non-eventful insider transaction.
Keywords
Vicor Corp, VICR, Form 4, Insider Trading, Stock Options, 10b5-1 Plan, Andrew D'Amico, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.